Application of epigallocatechin gallate in preparing product for preventing and treating human mammary cancer disease
A technology of epigallocatechin and gallocatechin, which is applied in the field of preparation of drugs for the treatment of human breast cancer, and can solve the problems of no reports
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Formula: 810 grams of EGCG, 990 grams of medicinal starch.
[0031] Put the above-mentioned components into a blender, fully stir and mix, and pack capsules with a capsule machine, each filling 0.3 g, to obtain 6000 EGCG capsules, each containing 135 mg of EGCG.
[0032] 1. To establish the parameters of the effect of EGCG on blood VEGF, HGF and OPN, levels of MMP9 and MMP2 enzyme activities in human breast cancer patients.
[0033] The patient took 3 EGCG capsules (100 mg / grain) orally each time, three times a day, and took EGCG continuously for 8 weeks. Fasting for 15 hours before oral administration for the first time, after taking a blood sample (control) on an empty stomach, orally take three (100 mg / grain) EGCG capsules, take blood samples after 2 hours, separate serum and plasma, and set aside. After one week, two weeks, four weeks, six weeks and eight weeks, samples were analyzed in the same way. The levels of related proteins in serum and plasma were detected...
Embodiment 2
[0044] Decreased serum vascular endothelial growth factor (VEGF) levels in human breast cancer patients after taking EGCG, an active ingredient of tea.
[0045] Materials and methods
[0046] Twenty human breast cancer patients were randomly divided into two groups. There were 10 cases in the experimental group and 10 cases in the control group. Aged 37-73 years old (average 52 years old). All human breast cancer patients received radiotherapy instead of chemotherapeutic drugs. The experimental group took EGCG capsules (containing EGCG135mg / capsule), 3 times a day, 3 capsules each time, for 6 weeks, and the control group took no medicine. Blood samples were collected from patients at 0, 1, 4, and 6 weeks. Every time a blood sample is collected from the patient, after fasting for 14 hours, immediately take EGCG3 capsules, and take a blood sample 2 hours later, separate the serum and plasma from the blood samples taken with the drug and those without the drug, for the detect...
Embodiment 3
[0052] Decreased plasma hepatocyte growth factor (HGF) levels in human breast cancer patients following administration of tea active ingredient EGCG.
[0053] Materials and methods
[0054] Twenty human breast cancer patients were randomly divided into two groups. There were 10 cases in the experimental group and 10 cases in the control group. Aged 37-73 years old (average 52 years old). All human breast cancer patients received radiotherapy instead of chemotherapeutic drugs. The experimental group took EGCG capsules (containing EGCG135mg / capsule), 3 times a day, 3 capsules each time, for 6 weeks, and the control group took no medicine. Blood samples were collected from patients at 0, 1, 4, and 6 weeks. Every time a blood sample was collected from the patient, after 14 hours of fasting, 3 capsules of EGCG were taken immediately, and blood samples were collected 2 hours later. Serum and plasma were separated from the blood samples taken and not taken for the detection and a...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com